E10.3492 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye

Name of the Condition

• Type 1 diabetes mellitus with severe nonprolative diabetic retinopathy without macular edema, left eye

Summary

Type 1 diabetes mellitus is a chronic autoimmune condition characterized by insufficient insulin production. When associated with severe nonproliferative diabetic retinopathy without macular edema, it indicates advanced retinal damage due to prolonged hyperglycemia. This stage involves widespread microaneurysms, intraretinal hemorrhages, venous beading, and intraretinal microvascular abnormalities without neovascularization or macular fluid accumulation. The left eye is specifically affected, requiring targeted monitoring to prevent progression to proliferative disease or vision loss.

Causes

Type 1 diabetes arises from an autoimmune response that destroys insulin-producing beta cells in the pancreas. Severe nonproliferative diabetic retinopathy without macular edema develops as a result of sustained high blood glucose levels, which damage retinal blood vessels over time. The exact mechanisms involve oxidative stress, inflammation, and vascular changes specific to ocular structures, leading to progressive retinal ischemia and structural damage without macular involvement in the left eye.

Risk Factors

• Poor glycemic control
• Duration of diabetes (longer exposure increases risk)
• Hypertension
• Dyslipidemia
• Smoking
• Genetic predisposition to diabetic eye disease

Symptoms

• Blurred or distorted vision in the left eye
• Floaters or spots in the visual field of the left eye
• Difficulty seeing in low light (left eye)
• Fluctuating vision in the left eye

Diagnosis

Diagnosis involves a comprehensive eye examination, including visual acuity testing, dilated retinal examination, and imaging studies such as optical coherence tomography (OCT) or fluorescein angiography to assess retinal changes. Blood glucose and HbA1c levels are evaluated to confirm diabetes control. The left eye is specifically examined to document the extent of retinal damage and rule out macular edema or proliferative changes.

Treatment Options

Treatment focuses on managing blood glucose levels to slow retinal progression. Laser photocoagulation may be used to reduce ischemia. Regular eye exams are critical to monitor for worsening disease. Anti-VEGF therapy is not typically indicated without macular edema or neovascularization. Blood pressure and lipid management support overall ocular health.

Prognosis and Follow-Up

Prognosis depends on glycemic control and timely intervention. Without proper management, severe nonproliferative diabetic retinopathy may progress to proliferative disease or vision loss. Follow-up includes regular dilated eye exams every 3–6 months, with more frequent visits if changes occur. Lifestyle modifications and medication adherence are essential to preserve vision.

Complications

• Progression to proliferative diabetic retinopathy
• Sudden vision loss from vitreous hemorrhage
• Macular edema (if disease advances)
• Retinal detachment
• Permanent vision impairment in the left eye

Lifestyle & Prevention

• Maintain tight glycemic control through insulin therapy and monitoring
• Control blood pressure and cholesterol levels
• Avoid smoking and limit alcohol intake
• Protect eyes from UV light with sunglasses
• Attend regular eye screenings to detect changes early

When to Seek Professional Help

Seek immediate care if you experience sudden vision loss, increased floaters, or flashes of light in the left eye, as these may indicate retinal detachment or hemorrhage. Schedule an urgent eye exam if vision worsens or new symptoms develop.

Tips for Medical Coders

Document the specific eye (left) and absence of macular edema clearly in clinical notes. Ensure the code E10.3492 is used only when the left eye is affected and macular edema is explicitly ruled out. Include details on retinal findings (e.g., microaneurysms, venous beading) to support the severity designation.